Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)
| 4.49 Delayed Data As of Feb 14 |  -0.40 / -8.18%Today’s Change | 4.38 Today|||52-Week Range 16.47 | -25.66% Year-to-Date |
Latest ZYNE News | Press Releases
No recent news for Zynerba Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.89 |
| Today’s open | 4.91 |
| Day’s range | 4.38 - 5.01 |
| Volume | 1,555,158 |
| Average volume (3 months) | 545,708 |
| Market cap | $102.8M |
Data as of 4:00pm ET, 02/14/2020
Growth & Valuation
| Earnings growth (last year) | -5.12% |
| Earnings growth (this year) | +41.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 528.69 |
| Price/Book | 1.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLSDClearside Biomedical... | -0.25 | -9.03% |
| CMRXChimerix Inc | +0.03 | +1.83% |
| SVRASavara Inc | -0.13 | -5.04% |
| ASRTAssertio Therapeutic... | -0.01 | -0.74% |
Data as of 4:00pm ET, 02/14/2020
Financials
| Next reporting date | March 19, 2020 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $86.0K |
| Annual profit (last year) | -$39.9M |
| Net profit margin | -46,408.34% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Devon, Pennsylvania |
Forecasts
